Skip to main content

Table.1 Univariate logistic regression analyses of factors associated with the use of complementary therapies among patients with systemic lupus erythematosus

From: Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study

Variable n (%) Odds ratio (95% CI) P
Total Regular use of complementary therapies   
351 (100) Use
300 (85.5)
Non-use
51 (14.5)
  
Sex
 Male 34 (9.7) 28 (82.4) 6 (17.6) 1  
 Female 317 (90.3) 272 (85.8) 45 (14.2) 1.30 (0.51–3.30) 0.588
Age interval (years)
 20–39 140 (39.9) 110 (78.6) 30 (21.4) 1  
  ≥ 40 211 (60.1) 190 (90.0) 21 (10.0) 2.47 (1.35–4.52) 0.003
Body mass index
 Normal weight 184 (52.4) 165 (89.7) 19 (10.3) 1  
 Underweight 48 (13.7) 41 (85.4) 7 (14.6) 0.67 (0.27–1.71) 0.407
 Overweight or obesity 119 (33.9) 94 (79.0) 25 (21.0) 0.43 (0.23–0.83) 0.011
Educational level
 High school or below 177 (50.4) 150 (84.7) 27 (15.3) 1  
 College or above 174 (49.6) 150 (86.2) 24 (13.8) 1.12 (0.62–2.04) 0.698
Marital status
 Single 118 (33.6) 98 (83.1) 20 (16.9) 1  
 Married, widowed, or divorced 233 (66.4) 202 (86.7) 31 (13.3) 1.33 (0.72–2.45) 0.361
Job change related to SLE
 No 248 (70.7) 213 (85.9) 35 (14.1) 1  
 Yes 103 (29.3) 87 (84.5) 16 (15.5) 0.89 (0.47–1.70) 0.731
Employment status
 Employed 222 (63.2) 186 (83.8) 36 (16.2) 1  
 Unemployed 129 (36.8) 114 (88.4) 15 (11.6) 1.47 (0.77–2.81) 0.242
Self-report health status
 Healthy 92 (26.2) 78 (84.8) 14 (15.2) 1  
 Not healthy or average 259 (73.8) 222 (85.7) 37 (14.3) 1.08 (0.55–2.10) 0.828
Disease duration, years
  < 10 126 (35.9) 104 (82.5) 22 (17.5) 1  
  ≥ 10 225 (64.1) 196 (87.1) 29 (12.9) 1.43 (0.78–2.61) 0.245
Age at diagnosis, years
 0–29 186 (53.0) 153 (82.3) 33 (17.7) 1  
  ≥ 30 165 (47.0) 147 (89.1) 18 (10.9) 1.76 (0.95–3.27) 0.072
Alcohol use in the past year
 Yes 81 (23.1) 61 (75.3) 20 (24.7) 1  
 No 270 (76.9) 239 (88.5) 31 (11.5) 2.53 (1.35–4.74) 0.004
Smoking in the past year
 Yes 34 (9.7) 25 (73.5) 9 (26.5) 1  
 No 317 (90.3) 275 (86.8) 42 (13.2) 2.36 (1.03–5.40) 0.042
Vigorous exercise in the past year
 Never 60 (17.1) 43 (71.7) 17 (28.3) 1  
 Yes 291 (82.9) 257 (88.3) 34 (11.7) 2.99 (1.54–5.82) 0.001
Sleep duration/day, hours
  ≥ 8 69 (19.7) 43 (71.7) 17 (28.3) 1  
  ≤ 7 282 (80.3) 257 (88.3) 34 (11.7) 2.99 (1.54–5.82) 0.001
Sleeping medication use
 No 253 (72.1) 210 (83.0) 43 (17.0) 1  
 Yes 98 (27.9) 90 (91.8) 8 (8.2) 2.30 (1.04–5.10) 0.039
SLEDAI-2 K, mean (SD) (n = 333) 4.9 (4.4) 4.7 (4.1) 6.2 (5.9) 0.94 (0.88–1.00) 0.035
Domain of LupusQoL, mean (SD)
 Physical health 81.3 (19.9) 80.1 (20.0) 88.4 (17.6) 0.74 (0.59–0.92) 0.008
 Emotional health 83.2 (19.8) 82.8 (19.9) 85.5 (18.8) 0.92 (0.78–1.09) 0.362
 Body image (n = 340) 82.9 (23.0) 83.0 (22.8) 82.5 (24.8) 1.01 (0.89–1.15) 0.904
 Pain 80.2 (26.5) 79.7 (26.9) 83.5 (23.6) 0.94 (0.83–1.07) 0.344
 Planning 81.2 (26.2) 80.7 (26.7) 84.6 (23.0) 0.94 (0.83–1.06) 0.319
 Fatigue 72.0 (23.5) 71.4 (23.7) 75.5 (21.9) 0.92 (0.81–1.06) 0.253
 Intimate relationships (n = 271) 74.3 (33.2) 72.9 (34.6) 81.4 (23.7) 0.92 (0.82–1.03) 0.129
 Burden to others 72.0 (29.9) 71.4 (30.3) 79.1 (27.4) 0.91 (0.81–1.02) 0.094
  1. CI confidence interval, SD standard deviation, SLE systemic lupus erythematosus, SLEDAI-2 K Systemic Lupus Erythematosus Disease Activity Index 2000
  2. The score of LupusQoL was multiplied by 10 in the regression analysis, and therefore, the odds ratio was per 10-point change in LupusQoL